Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
In a clinical trial, Fathi et al. show that a booster vaccination with a vector vaccine candidate against the highly pathogenic Middle East Respiratory Syndrome coronavirus is safe and strongly improves the immunity generated by primary immunization.
Bibliographic Details
| Main Authors: |
Anahita Fathi,
Christine Dahlke,
Verena Krähling,
Alexandra Kupke,
Nisreen M. A. Okba,
Matthijs P. Raadsen,
Jasmin Heidepriem,
Marcel A. Müller,
Grigori Paris,
Susan Lassen,
Michael Klüver,
Asisa Volz,
Till Koch,
My L. Ly,
Monika Friedrich,
Robert Fux,
Alina Tscherne,
Georgia Kalodimou,
Stefan Schmiedel,
Victor M. Corman,
Thomas Hesterkamp,
Christian Drosten,
Felix F. Loeffler,
Bart L. Haagmans,
Gerd Sutter,
Stephan Becker,
Marylyn M. Addo |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Portfolio
2022-07-01
|
|---|
| Series: | Nature Communications
|
|---|
| Online Access: | https://doi.org/10.1038/s41467-022-31557-0
|
|---|